Clinical Trial

Neoantigen Reactive T Cells c for Chinese Patients With Advanced Gastric Cancer

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated May 29, 2024 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to see the safety and efficient of neoantigen reactive T cells (NRTs) in the treatment of Chinese patients with advanced gastric cancer.
Trial Details
NCT Number NCT06432075
Lead Sponsor First Affiliated Hospital of Wenzhou Medical University
Conditions Advanced Gastric Cancer
Enrollment 20 participants
Start Date 2024-06-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2024-05-29